- Home
- BMRN vs HTHT Comparison
BMRN vs HTHT Comparison
Compare BMRN & HTHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- HTHT
- Stock Information
- Founded
- BMRN 1996
- HTHT 2005
- Country
- BMRN United States
- HTHT China
- Employees
- BMRN N/A
- HTHT N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- HTHT Hotels/Resorts
- Sector
- BMRN Health Care
- HTHT Consumer Discretionary
- Exchange
- BMRN Nasdaq
- HTHT Nasdaq
- Market Cap
- BMRN 12.1B
- HTHT 10.2B
- IPO Year
- BMRN 1999
- HTHT 2010
- Fundamental
- Price
- BMRN $59.01
- HTHT $33.29
- Analyst Decision
- BMRN Buy
- HTHT Strong Buy
- Analyst Count
- BMRN 23
- HTHT 2
- Target Price
- BMRN $93.73
- HTHT $45.00
- AVG Volume (30 Days)
- BMRN 1.8M
- HTHT 1.7M
- Earning Date
- BMRN 08-04-2025
- HTHT 08-19-2025
- Dividend Yield
- BMRN N/A
- HTHT 5.85%
- EPS Growth
- BMRN 152.82
- HTHT N/A
- EPS
- BMRN 2.71
- HTHT 1.42
- Revenue
- BMRN $2,950,227,000.00
- HTHT $3,308,482,052.00
- Revenue This Year
- BMRN $12.27
- HTHT $7.30
- Revenue Next Year
- BMRN $9.99
- HTHT $8.21
- P/E Ratio
- BMRN $21.81
- HTHT $23.87
- Revenue Growth
- BMRN 19.36
- HTHT 5.86
- 52 Week Low
- BMRN $52.93
- HTHT $27.03
- 52 Week High
- BMRN $94.85
- HTHT $42.98
- Technical
- Relative Strength Index (RSI)
- BMRN 55.66
- HTHT 45.70
- Support Level
- BMRN $56.48
- HTHT $32.81
- Resistance Level
- BMRN $60.43
- HTHT $34.31
- Average True Range (ATR)
- BMRN 1.52
- HTHT 0.82
- MACD
- BMRN 0.23
- HTHT 0.11
- Stochastic Oscillator
- BMRN 64.05
- HTHT 46.68
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About HTHT H World Group Limited
H World Group Ltd is a multi-brand hotel group in China with international operations. It operates in the leased, managed, and franchised models. The company has two operating segments: legacy Huazhu and legacy DH. Its brand and product offering includes Economy hotel brands: HanTing Hotel, Ni Hao Hotel, Hi Inn, Elan Hotel, Zleep Hotels, and Ibis Hotel, Midscale hotel brands: JI Hotel, Orange Hotel, Starway Hotel and Ibis Styles Hotel, Upper midscale hotel brands: Crystal Orange Hotel, IntercityHotel, Manxin Hotel, Mercure Hotel, Madison Hotel, Novotel Hotel, CitiGO Hotel and MAXX by Steigenberger, Upscale hotel brands: Joya Hotel, Blossom House, Steigenberger Hotels & Resorts, Jaz in the City, and Grand Mercure; and Luxury hotel brand: Steigenberger Icon and Song Hotels.